Open Access
Open access
том 16 издание 2 страницы e0242890

High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector

Тип публикацииJournal Article
Дата публикации2021-02-02
scimago Q1
wos Q2
БС1
SJR0.803
CiteScore5.4
Impact factor2.6
ISSN19326203
Multidisciplinary
Краткое описание

The spike (S) protein is one of the three proteins forming the coronaviruses’ viral envelope. The S protein of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has a spatial structure similar to the S proteins of other mammalian coronaviruses, except for a unique receptor-binding domain (RBD), which is a significant inducer of host immune response. Recombinant SARS-CoV-2 RBD is widely used as a highly specific minimal antigen for serological tests. Correct exposure of antigenic determinants has a significant impact on the accuracy of such tests–the antigen has to be correctly folded, contain no potentially antigenic non-vertebrate glycans, and, preferably, should have a glycosylation pattern similar to the native S protein. Based on the previously developed p1.1 vector, containing the regulatory sequences of the Eukaryotic translation elongation factor 1 alpha gene (EEF1A1) from Chinese hamster, we created two expression constructs encoding SARS-CoV-2 RBD with C-terminal c-myc and polyhistidine tags. RBDv1 contained a native viral signal peptide, RBDv2 –human tPA signal peptide. We transfected a CHO DG44 cell line, selected stably transfected cells, and performed a few rounds of methotrexate-driven amplification of the genetic cassette in the genome. For the RBDv2 variant, a high-yield clonal producer cell line was obtained. We developed a simple purification scheme that consistently yielded up to 30 mg of RBD protein per liter of the simple shake flask cell culture. Purified proteins were analyzed by polyacrylamide gel electrophoresis in reducing and non-reducing conditions and gel filtration; for RBDv2 protein, the monomeric form content exceeded 90% for several series. Deglycosylation with PNGase F and mass spectrometry confirmed the presence of N-glycosylation. The antigen produced by the described technique is suitable for serological tests and subunit vaccine studies.

Найдено 
Найдено 

Топ-30

Журналы

1
2
Biosensors
2 публикации, 8.33%
International Journal of Molecular Sciences
1 публикация, 4.17%
Diagnostics
1 публикация, 4.17%
PeerJ
1 публикация, 4.17%
Pathogens
1 публикация, 4.17%
Frontiers in Immunology
1 публикация, 4.17%
Frontiers in Microbiology
1 публикация, 4.17%
Scientific Reports
1 публикация, 4.17%
Molecular Biotechnology
1 публикация, 4.17%
Protein Expression and Purification
1 публикация, 4.17%
Computers in Biology and Medicine
1 публикация, 4.17%
Biochemical and Biophysical Research Communications
1 публикация, 4.17%
Biotechnology Reports
1 публикация, 4.17%
EBioMedicine
1 публикация, 4.17%
Biotechnology Journal
1 публикация, 4.17%
Immunity, inflammation and disease
1 публикация, 4.17%
Molecular Genetics, Microbiology and Virology
1 публикация, 4.17%
Frontiers in Bioengineering and Biotechnology
1 публикация, 4.17%
FEBS Open Bio
1 публикация, 4.17%
Organic and Biomolecular Chemistry
1 публикация, 4.17%
Medicine in Drug Discovery
1 публикация, 4.17%
Molecular Genetics, Microbiology and Virology = Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya
1 публикация, 4.17%
Protein Journal
1 публикация, 4.17%
1
2

Издатели

1
2
3
4
5
6
Elsevier
6 публикаций, 25%
MDPI
5 публикаций, 20.83%
Frontiers Media S.A.
3 публикации, 12.5%
Springer Nature
3 публикации, 12.5%
Wiley
3 публикации, 12.5%
PeerJ
1 публикация, 4.17%
Pleiades Publishing
1 публикация, 4.17%
Royal Society of Chemistry (RSC)
1 публикация, 4.17%
Media Sphere Publishing House
1 публикация, 4.17%
1
2
3
4
5
6
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
24
Поделиться
Цитировать
ГОСТ |
Цитировать
Sinegubova M. V. et al. High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector // PLoS ONE. 2021. Vol. 16. No. 2. p. e0242890.
ГОСТ со всеми авторами (до 50) Скопировать
Sinegubova M. V., Orlova E. A., Kovnir S. V., Dayanova L. K., Vorobiev I. I. High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector // PLoS ONE. 2021. Vol. 16. No. 2. p. e0242890.
RIS |
Цитировать
TY - JOUR
DO - 10.1371/journal.pone.0242890
UR - https://doi.org/10.1371/journal.pone.0242890
TI - High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector
T2 - PLoS ONE
AU - Sinegubova, Maria V.
AU - Orlova, E A
AU - Kovnir, Sergey V
AU - Dayanova, Lutsia K
AU - Vorobiev, Ivan I
PY - 2021
DA - 2021/02/02
PB - Public Library of Science (PLoS)
SP - e0242890
IS - 2
VL - 16
PMID - 33529230
SN - 1932-6203
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2021_Sinegubova,
author = {Maria V. Sinegubova and E A Orlova and Sergey V Kovnir and Lutsia K Dayanova and Ivan I Vorobiev},
title = {High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector},
journal = {PLoS ONE},
year = {2021},
volume = {16},
publisher = {Public Library of Science (PLoS)},
month = {feb},
url = {https://doi.org/10.1371/journal.pone.0242890},
number = {2},
pages = {e0242890},
doi = {10.1371/journal.pone.0242890}
}
MLA
Цитировать
Sinegubova, Maria V., et al. “High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector.” PLoS ONE, vol. 16, no. 2, Feb. 2021, p. e0242890. https://doi.org/10.1371/journal.pone.0242890.